First, HPV-positive 2A3 and HPV-negative FaDu HNSCC cells were treated with HDAC6-selective inhibitor ACY-241 and BET inhibitor JQ1 as monotherapy. Here, HDAC6 is linked to head and neck squamous cell carcinoma.